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Objective: This study used a canine model of abdominal aortic aneurysms (AAAs) to compare intra-aneurysmal pressure
and thrombus formation after exclusion with Dacron and expanded polytetrafluoroethylene (ePTFE) stent-grafts.
Methods: Prosthetic AAAs with implanted strain-gauge pressure transducers were treated by stent-graft exclusion using
Food and Drug Administration-approved devices in 10 mongrel dogs: five Dacron (AneuRx) and five ePTFE (original
Excluder). Intra-aneurysmal pressure was measured over 4 weeks after AAA exclusion and indexed to the systemic
pressure, represented as a percentage of a simultaneously obtained systemic pressure (value  1.0). Magnetic resonance
imaging (MRI) of the intra-aneurysmal thrombus was performed at 1, 2, and 4 weeks after exclusion and expressed as a
signal-to-noise ratio (S:N) to control for background signal intensity. Comparisons of pressures and S:N between the two
stent-grafts was analyzed with the Student’s t test. Intra-aneurysmal thrombus was characterized histologically.
Results: In animals excluded with both Dacron and ePTFE stent-grafts, the intra-aneurysmal pressure was nonpulsatile and
reduced to <30% of systemic pressure. Significantly greater pressure transmission was observed after AAA exclusion using
ePTFE compared with Dacron stent grafts (systolic pressure: ePTFE, 0.28  0.12 vs Dacron, 0.11  0.02, P < .001; mean
pressure: ePTFE, 0.16 0.08 vs Dacron, 0.06 0.02, P< .001). MRI confirmed the absence of perfusion in all aneurysms.
The T1-weighted signal intensity remained persistently elevated (S:N at 1 week, 2.7  0.4 vs 2 weeks, 4.0  0.2 vs 4 weeks,
5.4  1.3) in ePTFE-treated intra-aneurysmal thrombus, suggesting an absence of thrombus organization. In contrast,
progressive evolution ofT1 signal intensity in aneurysms excludedbyDacron stent-graftswas consistentwithmaturation from
intact red blood cells (S:N at 1 week, 3.3  0.4) to methemoglobin (S:N at 2 weeks, 6.1  0.8), and then hemosiderin and
ferritin (S:Nat 4weeks, 2.40.5).Histologically, ePTFE-excluded aneurysms containedpoorly organized thrombuswith red
blood cell fragments and haphazardly arranged fibrin deposition indicative of active remodeling and continued influx of
transudated serum. In aneurysms excluded byDacron stent-grafts, dense, mature collagenous connective tissue and organized
fibrin were present, indicative of greater thrombus organization.
Conclusions: Stent-graft treatment reduces intra-aneurysmal pressure to <30% of systemic pressure when no endoleak is
present; however, significantly greater pressure is present in aneurysms treated with porous ePTFE stent-grafts than
Dacron grafts. Histologic andMRI imaging analysis suggest that active transudation of serous blood components may be
contributing to this increased intra-aneurysmal pressure. ( J Vasc Surg 2006;43:109-16.)
Clinical Relevance: Continued expansion of abdominal aortic aneurysms (AAAs) in the absence of an endoleak after
endovascular repair is thought to result from endotension. Clinical studies have shown that AAAs excluded with grafts made
from expanded polytetrafluoroethylene (ePTFE) are more likely to result in aneurysm sac expansion, which may be the result
of transudation of serous blood components through the stent-graft. This study used an animal model of AAA to examine
aneurysm sac pressure and resulting thrombus in abdominal aortic aneurysms treated with either ePTFE or Dacron stent-grafts.
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aneurysms (AAAs) by excluding the aneurysm sac from
arterial circulation. Endotension has been proposed to
account for the continued expansion of the aneurysm sac
after endovascular repair in the absence of perfusion or
endoleak.1 This is associated with a nonpulsatile pressure
that is approximately one third of systemic pressure. Pre-
liminary clinical data suggest that stent-grafts constructed
from expanded polytetrafluoroethylene (ePTFE) may re-
sult in continued expansion of the AAA, despite complete
exclusion of the aneurysm from the arterial circulation as
evidenced by the absence of an endoleak.2-4 In addition,
aneurysm sac hygromas, with the appearance of a gelati-
nous sac content, have been described with ePTFE grafts in
several case reports.5-7 This study sought to compare intra-
aneurysmal pressure and content after exclusion with United
States Food and Drug Administration (FDA)-approved Da-
cron or ePTFE stent-grafts in a canine model of AAA.
METHODS
Prosthetic AAAs with implanted strain-gauge pressure
transducers were treated by stent-graft exclusion using
FDA-approved devices in 10 mongrel dogs: five Dacron
AneuRx (AAA Stent-Graft System, Medtronic, Santa Rosa,
Calif) and five porous ePTFE original Excluder (WL Gore
and Assoc, Flagstaff, Ariz). Each of the dogs weighed 25 to
35 kg. The procedures and handling of the animals were
reviewed and approved by the Institutional Animal Care
and Use Committee at Weill Medical College of Cornell
University. All procedures were in accordance with the
Guide for the Care and Use of Laboratory Animals by the
Institute of Laboratory Animal Resources, Commission on
Life Sciences.8
Pressure transducer and prosthetic aneurysm creation.
An implantable, solid-state, strain-gauge pressure trans-
ducer (Konigsberg Instruments, Pasadena, Calif) was used
for daily monitoring of systemic and intra-aneurysmal pres-
sure. The accuracy of the transducer has been confirmed in
various media in vitro and in vivo, including liquid, gelati-
nous, and solid environments.9,10 Continuous pressure
monitoring and data storage were performed by using data
recording software fromData Integrated Scientific Systems
(DISS, Detroit, Mich). Before implantation and after ex-
plantation, calibration of the transducer was preformed.
Daily systemic and intra-aneurysmal pressures were taken
for 4 weeks after aneurysm creation and exclusion. The
intra-aneurysmal pressure was indexed to the systemic pres-
sure, which was obtained simultaneously; therefore, an
index pressure of 0.28 represents 28% of the systemic
pressure.
Balloon dilation was used to create the prosthetic an-
eurysm from thin-walled PTFE (8-mm-diameter Impra,
Bard Peripheral Vascular, Tempe, Ariz) before implanta-
tion. The final diameter of the prosthetic aneurysm was 30
mm. The pressure transducer was approximated to the
luminal surface of the prosthetic aneurysm and secured in
place (Fig 1).Implantation of prosthetic aneurysm and pressure
transducers. The animals were fasted overnight and on
the day of surgery were anesthetized (induction, thiopental
8 mg/kg; maintenance, isoflurane 2%), intubated, and
ventilated. The abdominal aorta from the level of the renal
arteries to the trifurcation was exposed via a midline ab-
dominal incision. After obtaining proximal and distal con-
trol, the aorta was completely transected. The prosthetic
30-mm-diameter aneurysm containing an intraluminal
strain-gauge pressure transducer was sewn to the transected
ends of the aorta as an interposition graft (Fig 2). A second
strain-gauge pressure transducer was placed in the native
aorta proximal to the aneurysm. Systemic anticoagulation
with unfractionated sodium heparin (2000 U intrave-
nously) was maintained throughout the period of arterial
clamping.
Exclusion of the aneurysm. Aneurysm exclusion was
performed during the same procedure (Fig 3) via the
midline laparotomy incision by using one of two different
stent-grafts (Dacron, five animals; ePTFE, five animals).
Exclusion was performed via the midline laparotomy inci-
sion because the delivery system (16F) for the stent-grafts is
larger than the canine femoral artery. The FDA-approved
Dacron stent-graft used in this study was the AneuRx AAA
Stent Graft System (iliac limb, resilient high-density graft
material), which consists of an exoskeleton of nitinol over a
polyethylene terephthalate (Dacron) graft material. The
Dacron stent-graft porosity is defined by its water integral
permeability of 211 26 mL/min/cm2, which is the stan-
dardmethod formeasuring the porosity of industrial fabrics
such as Dacron. The FDA-approved ePTFE stent graft
utilized in this study was the original Excluder (original
high porosity) made of nitinol-covered ePTFE. Because
ePTFE is hydrophobic, the water integral permeability is
Fig 1. An expanded polytetrafluoroethylene aneurysm with an
implanted pressure transducer. The transducer cable is tunneled
through the abdominal wall and tracked subcutaneously toward
the dorsal aspect of the animal. The metal connector exits the
interscapular skin, caudal to the neck. This allows continuous
intra-aneurysmal pressure measurement.not a reliable measurement of its porosity; therefore, ex-
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internodal distance, which for the original Excluder is 25m.
The dogs were randomized to receive one of the two
grafts before the start of each surgery. In five animals, a
Dacron stent-graft (12-mmdiameter 5.5-cm length) was
deployed, and in five animals an ePTFE stent-graft (12-mm
diameter  7-cm length) was deployed. All stent-grafts
were introduced through the distal aorta, with a sheath
being used for the ePTFE stent graft and no sheath for the
AneuRx stent-graft. The additional length of this stent-
graft was placed in the native vessels, creating a hemostatic
seal in all cases. The degree of oversizing was equal in both
stent-grafts, and postdeployment angioplasty with 8-mm
balloons was done in all cases. Intraoperative angiography
withmultiple oblique projections was performed in all cases
after stent-graft deployment to confirm the integrity of the
exclusion from antegrade perfusion (Fig 4). In addition,
flush aortography was performed 4 weeks after stent graft
exclusion (before sacrifice) to confirm absence of en-
doleaks.
The peritoneal cavity was closed, and the cables from
the pressure transducers were tunneled laterally through
the abdominal wall and tracked subcutaneously to exit the
skin between the scapulae. The animals were extubated and
Fig 2. The appearance of a prosthetic infrarenal aneurysm (AAA)
in situ. The cable of the pressure transducer (Tr) is seen at the right
side of the image as it exits the wall of the aneurysm. Trifurcation
is beyond the distal aspect (D) of the aorta shown in the photo.allowed to recover overnight. All animals received clopi-dogrel (75 mg/day) (Sanofi-Synthelabo Pharmaceuticals,
New York, NY) starting the day of surgery and continuing
until euthanasia.
Magnetic resonance imaging. Before magnetic reso-
nance imaging (MRI), the animals were premedicated,
anesthetized, intubated, and mechanically ventilated in a
manner similar to preparation for operative procedures.
T1-weighted MRI images and gadolinium-enhanced mag-
netic resonance angiography (MRA) images were obtained
by using a fast spoiled gradient-recalled protocol in a 3.0
TeslaMRI system (GEMedical Systems,Waukesha,Wis) at
1, 2, and 4 weeks after aneurysm exclusion. Post processing
with GEMS 4.0 Fiesta video imaging software (GEMedical
Systems) was used to analyze the images (Fig 5).
A localizer scan was obtained in the coronal, axial, and
sagittal planes and was used to determine subsequent im-
aging in the axial plane for T1-weighted images and cine-
gated MRA. T1-weighted images were obtained from the
renal arteries to the abdominal aortic trifurcation by using
double inversion recovery fast spin echo sequences. Param-
eters of T1-weighted images were TR, 350 milliseconds;
TE, 14 milliseconds; FOV, 20 cm; and matrix, 256 256.
The T1-weighted images were used to analyze the charac-
teristics of the thrombus, quantified by determining the
signal-to-noise ratio (S:N). The S:N was calculating as the
ratio of the signal in the area of the thrombus compared
with the signal intensity of the air in the same image,
allowing a standardization of the MRI signal intensity (Fig
5) This well-established technique helps eliminate inter-
examination variability. A radiologist blinded to the histo-
logic results determined the signal intensity of the throm-
Fig 3. Schematic illustration of prosthetic aneurysm. A, Dilated
segment of polytetrafluoroethylene (PTFE) is inserted as an inter-
position graft within the transected infrarenal aorta to create an
abdominal aortic aneurysm (AAA). A strain-gauge pressure trans-
ducer (Tr) allows intra-aneurysmal pressure determination.B,The
aneurysm is excluded with a PTFE or Dacron stent-graft (SG).bus in at least three different sections for each time point.
ft (SG
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aneurysm exclusion via an injection of Sleepaway (Ft
Dodge Laboratories, Ft Dodge, Iowa).
Histology. The aneurysm was perfusion-fixed in 3%
glutaraldehyde buffered to pH 7.4 with sodium cacodylate
for histopathologic investigation. The aorta was divided
longitudinally to remove the stent-graft before paraffin
embedding. Transverse, longitudinal, and oblique sections
of the aneurysm content were embedded in paraffin. Intra-
aneurysmal thrombus was characterized histologically us-
ing hematoxylin and eosin, Masson’s trichrome, and Mal-
lory’s phosphotungstic acid hematoxylin (PTAH) stains.
Masson’s trichrome was used to detect collagen, which is
labelled blue, and PTAH was used to identify fibrin, la-
belled purple.
Statistics. Intra-aneurysmal pressure measurements
were indexed to the systemic pressure, which was obtained
simultaneously. The intra-aneurysmal pressure is represented
as a percentage of the systemic pressure, with the systemic
pressure having a value of 1.0. Results are represented as the
mean  standard deviation. Continuous variables were
analyzed using the Student’s t test, with statistical signifi-
cance assumed at P  .05. All statistical analysis was per-
formed with SPSS (version 10) (SPSS, Chicago, Ill) for
Windows (Microsoft, Redmond, Wash).
RESULTS
Complete exclusion from antegrade perfusion was
Fig 4. Intraoperative angiography used during endovas
the prosthetic aneurysm (AAA) with an indwelling stra
demonstrates the use of an endoluminal aortic stent-graachieved in all animals. No endoleaks were present, whichwas confirmed by MRI throughout the study and on an-
giography at the time of euthanasia. In animals excluded
with both Dacron and ePTFE stent-grafts, the sac pressure
was nonpulsatile and reduced to30% of systemic pressure
(Table I). In aneurysms excluded with ePTFE stent-grafts,
the systolic pressure within the aneurysm sac after exclusion
was reduced to 0.28 0.12 compared with 1.0 for systemic
pressure. Aneurysms excluded withDacron stent-grafts had
a significantly lower intra-aneurysmal sac systolic pressure
of 0.11  0.02 (1.0 for systemic pressure compared with
ePTFE stent-grafts, P  .0001).
The mean intra-aneurysmal pressure followed a similar
pattern. In aneurysms excluded with ePTFE stent-grafts,
mean intra-aneurysmal pressure was reduced to 0.16 
0.08 of the mean systemic pressure (1.0). The mean
intra-aneurysmal pressure in dogs treated with Dacron
stent-grafts was significantly less, reduced to 0.06 0.02
compared with 1.0 for the mean systemic pressure (P 
.0001).
Analysis of the MRI T1-weighted signal intensity of
AAAs excluded by ePTFE stent-grafts continued to in-
crease for the duration of the study for up to 4 weeks. The
mean S:N of AAAs excluded by ePTFE stent-grafts was
initially 2.7 0.4, increasing to 4.0 0.2 and 5.4 1.3 at
1, 2, and 4 weeks, respectively (Table II). This contrasted
with the T1-weighted signal intensity of AAAs excluded
with Dacron stent-grafts, which initially had a mean S:N
exclusion of aneurysms. A, An angiogram demonstrates
uge transducer (Tr). B, Digital-subtraction angiogram
) to exclude the same aneurysm.cular
in-gaof 3.3 0.4 at 1 week, peaked at 2 weeks to a mean S:N of
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4 weeks.
The progressive evolution of the signal intensity in
aneurysms excluded with Dacron stent-grafts is suggestive
of maturation of the thrombus from intact red blood cells
to methemoglobin and eventually to hemosiderin and
ferritin, as has been observed in previous studies per-
Fig 5. A, Magnetic resonance angiography with gad
exclusion with a stent-graft (SG). B, T1-weighted magn
intensity (S:N) from the AAA sac. The area of high inten
the magnetic resonance axial image demonstrates the s
transducer (TR) exiting from the aneurysm sac.
Table I. Intra-aneurysmal pressure analyzed by type of
stent-graft used to exclude the aneurysm
Systolic pressure* Mean pressure*
Dacron (AneuRx) 0.11  0.02 0.06  0.02
ePTFE (original excluder) 0.28  0.12 0.16  0.08
Systemic pressure 1.0 1.0
P† .0001 .0001
ePTFE, Expanded polytetrafluoroethylene.
*All pressures listed were after endovascular exclusion and are indexed as a
percentage of systemic pressure.
†Student’s t test.formed with this model. The persistent elevation of theT1-weighted signal intensity in ePTFE-treated AAAs sug-
gests active thrombus remodeling and an absence of throm-
bus organization.
Histologic analysis confirmed the MRI findings. For all
animals, histology was uniform throughout the AAA sac,
including the interface of the thrombus and the stent-graft.
m demonstrates aneurysm (AAA) after endovascular
esonance axial image demonstrates acquisition of signal
represents the lumen of the stent-graft. C, Schematic of
graft (SG) and the aneurysm sac (AAA) with pressure
Table II. Changing magnetic resonance imaging signal
intensity over time after endovascular exclusion of
abdominal aortic aneurysms with stent grafts made either
of Dacron or ePTFE
Time*
Type of stent-graft
P†Dacron ePTFE
1 week 3.3  0.4 2.7  0.4 .02
2 weeks 6.1  0.8 4.0  0.2 .001
4 weeks 2.4  0.5 5.4  1.3 .001
ePTFE, Expanded polytetrafluoroethylene.
*Time after endovascular exclusion.
†Student’s t test.oliniu
etic r
sity
tent-AAAs excluded by ePTFE stent-grafts resulted in an acute
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staining demonstrated the absence of either collagen or
granulation tissue. The thrombus was poorly organized,
with red blood cell fragments and haphazardly arranged
PTAH-positive fibrin deposition indicative of active remodel-
Fig 6. Comparison of histology of aneurysm sacs rem
endovascular treatment with either expanded polytetrafl
pictures, T represents thrombus, G represents prosthetic
eosin staining of tissue demonstrates overview of the his
wall 4 weeks after exclusion with a Dacron stent-graft
demonstrates chronic thrombus in abdominal aortic aneu
C,Masson’s trichrome staining for collagen demonstrate
sac after exclusion by an ePTFE stent-graft (10).D,Ma
fibrin of aneurysm sac and contents demonstrates well-o
Dacron stent-graft (20). PTAH staining for fibrin dem
sac after exclusion by a Dacron stent-graft (10).ing and continued influx of transudated serum (Fig 6).In contrast, AAAs excluded by Dacron stent-grafts
resulted in thrombi that were well organized and chroni-
cally composed mostly of granulation tissue. Trichrome
staining confirmed the presence of dense, mature collage-
nous connective tissue, with hemosiderin and hematoidin
from canines with prosthetic aneurysms 4 weeks after
ethylene (ePTFE) or Dacron stent-grafts. Throughout
rysm; Fib, fibrin, and Col, collagen. A,Hematoxylin and
y of aneurysm sac contents and prosthetic aneurysm sac
. B, Masson’s trichrome staining for collagen (arrow)
(AAA) sac after exclusion by a Dacron stent-graft (40).
of collagen, indicated by absence of blue labeling in AAA
s phosphotungstic acid hematoxylin staining (PTAH) for
ized fibrin in thrombus of AAA sac after exclusion by a
ates disorganized, limited fibrin in thrombus of an AAAoved
uoro
aneu
tolog
(4)
rysm
s lack
llory’
rgan
onstrdeposition. The fibrin was well organized as demonstrated
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to the prosthetic (PTFE) aneurysm at the time of sacrifice.
DISCUSSION
The success of the endovascular treatment of AAAs is
based on the elimination of arterial perfusion from the
aneurysm sac. In animals excluded with both Dacron and
ePTFE stent-grafts, the intra-aneurysmal pressure was non-
pulsatile and reduced to 30% of systemic pressure, with
significantly greater pressure present in aneurysms treated
with porous ePTFE stent-grafts compared with Dacron
stent-grafts. Aneurysms excluded with ePTFE stent-grafts
resulted in sac thrombi that suggested active thrombus
remodeling, whereas sac thrombi in AAAs excluded with
Dacron stent-grafts were made of connective tissue, sug-
gesting chronic thrombus.
The findings of this present study support what has
been observed in the clinical setting. Device-specific out-
comes after endovascular AAA repair have been evaluated
in multiple studies. In one study comparing six devices, the
original porous Excluder device was associated with the
lowest rate of aneurysm size reduction at 36 months of
follow-up.2 In the multicenter trial of the original Ex-
cluder, only 19% of patients had AAA sac regression,
whereas 14% had AAA sac enlargement at 2 years.3 A
single-institute study of patients treated with the original
Excluder found that the probability of freedom from sac
growth or re-expansion at 4 years was only 43%.4
AAA sac hygromas with the appearance of viscous,
gelatinous sac content have been described with ePTFE
grafts in several case reports after open and endovascular
repair. The formation of these “seromas” around prosthetic
(PTFE) grafts used for hemodialysis access and subclavian
artery-pulmonary artery shunts has long been known and
reported in the literature since the early 1980s.11 Wil-
liams11 described a 12-cm cystic mass filled with a seroma-
like fluid surrounding a patent PTFE graft 2.5 years after
open AAA repair and was one of the first to hypothesize
ultrafiltration through the graft as a potential cause. Ris-
berg et al12 described three cases of aneurysm sac hygromas
after repair of AAAs using PTFE grafts: two occurred after
endovascular repair and one after open repair. Analysis of
the fluid drained from these hygromas indicated activation
of both the coagulation and fibrinolytic systems.12 An
aneurysm sac hygroma was discovered 18 months after
thoracic endograft repair (ePTFE stent-graft) when the
patient became dyspneic.5 A rupture related to an hygroma
was described in a case series of five patients with symptom-
atic sac enlargement after open AAA repair with PTFE
grafts. During laparotomy, a seroma with gelatinous mate-
rial was discovered that histologically revealed degenerate
red blood cells and amorphous eosinophilic material.6
In this present study, AAAs excluded with ePTFE
stent-grafts resulted in thrombi that histologically were
consistent with an acute thrombus, with red blood cell
fragments and disorganized fibrin, whereas the thrombi of
AAAs excluded with Dacron stent-grafts were mostly com-
posed of collagen or granulation tissue, consistent with achronic thrombus. Although the level of organization at 4
weeks was less in ePTFE stent-grafts, given additional time,
further organization may have occurred.
Thrombus formation in the aneurysm sac is influenced
by stasis of blood that occurs after the aneurysm is excluded
from antegrade flow. This stasis leads to fibrin deposition
and also prevents the inflow of inhibitors of clotting factors,
which helps to allow the formation of an organized throm-
bus. Without the inflow of fibrinolytic factors, the throm-
bus in the aneurysm sac is eventually converted into a
subendothelial mass of connective tissue that can poten-
tially recanalize.13
Magnetic resonance imaging has been used to help
identify the stages of thrombus formation in both animal
models and human disease. This knowledge is based on
studies of acute cerebral hemorrhage that demonstrated the
changing appearance of MRI signal intensity is secondary
to the interactions of the molecules of hemoglobin degra-
dation (oxyhemoglobin, deoxyhemoglobin, methemoglo-
bin, ferritin, and hemosiderin) and the changing hydration
state of the hemorrhage.14 A swine model of acutely
formed carotid thrombi found that the evolution of MRI
appearance correlated to the histologic progression of the
thrombus (red blood cells and fibrin ¡ cellular debris ¡
connective tissue¡ organized collagen). The study found
that the MRI signal intensity demonstrated a rapid increase
followed by a decline as thrombus became stable.15
In addition, previous work done on this canine model
demonstrated that the changing MRI signal intensity cor-
responds to the evolution of the thrombus over time. In
this present study, a similar pattern of increase in signal
intensity followed by decline over time was seen in those
aneurysms excluded with Dacron stent-grafts, whereas the
signal intensity remained elevated in aneurysms excluded
with ePTFE stent-grafts, which correlated with the differ-
ent histologic findings.
AAAs excluded by ePTFE stent-grafts were found to
have significantly higher aneurysm sac pressures than those
that were excluded with Dacron stent-grafts, without any
evidence of endoleaks. Endotension is proposed to account
for continued aneurysm expansion after endovascular repair
in the absence of aneurysm perfusion.1 In a small case
series, endotension was found to be a nonpulsatile sac
pressure that was approximately one third of systemic pres-
sure.7 Potential causes of endotension include degradation
of the aneurysm sac thrombus and ultrafiltration through
the graft material.
Sjogren et al16 postulated that the pressure in aneurysm
sacs may trigger an upregulation of tissue plasminogen
activator, increasing the fibrinolytic activity and resulting in
the lysis of the thrombus. The increased pressure in the
aneurysm sac from endotension has the potential to result
in an increase in the aneurysm sac size, which in multiple
studies has been seen to more commonly occur after repair
with the original Excluder than grafts made of Dacron,
including the AneuRx stent-graft.2-4 Reports of rare rup-
tures after endograft repair have been associated with most
stent-grafts and are usually secondary to fixation of the
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ment for known endoleaks.17
Graft material and porosity have significant implica-
tions regarding the endovascular repair of AAAs. The po-
rosity of the prosthetic graft material is critical to its ability to
create a hemostatic seal and prevent hemorrhage through the
graft. Previous experimental research utilizing a canine
model of AAA evaluated the effect of stent-graft porosity
on pressure transmission to the aneurysm sac after treat-
ment with an endovascular stent-graft.10 In this previous
study, nonporous stent-grafts were demonstrated to reduce
pressure transmission to the aneurysm sac to 10% of
systemic pressure. In contrast, the highly porous co-knit
graft resulted in transmission of pressure that was 80% of
systemic pressure.18 Our study did not use any knitted
Dacron grafts.
In this present study, the differences in porosity of the
two stent-grafts evaluated are likely to be a significant factor
in the increased pressure observed in the aneurysm sac of
AAAs excluded with ePTFE stent-grafts. However, differ-
ences in the materials themselves may also contribute to
these differences. Increased transudation of fluid through
the ePTFE stent-graft may occur because of characteristics
specific to the material. Normally, ePTFE is hydrophobic
but may become “wettable” if exposed to certain agents
such as Betadine (Purdue Frederick Co, Norwalk, Conn) or
blood.12 Finally, some studies have shown that transuda-
tion of fluid through PTFE may occur because of failure of
the fibroblasts to incorporate the graft.19
CONCLUSION
In this animal model of AAA, we found that endovas-
cular treatment with either Dacron or ePTFE stent-grafts
reduces the mean intra-aneurysmal pressure to a nonpulsa-
tile pressure that is 30% of systemic pressure. However,
significantly greater pressure was present in aneurysms
treated with porous ePTFE stent-grafts than Dacron grafts.
Histology and MRI suggest transudation of serous blood
components into aneurysm sacs treated with ePTFE stent-
grafts that may contribute to increased intra-aneurysmal
pressure. This transudation of serous blood components
may explain the clinical finding of expansion of the aneu-
rysm sac in the absence of an endoleak after treatment with
ePTFE stent-grafts. These findings provide a mechanism
for the findings observed clinically, reflecting properties of
the original Excluder. However, further studies will be
necessary to completely characterize the clinical signifi-
cance of this endotension.
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